Meet the Speakers of 2019

Plenary Speakers

Todd J. Brinton, MD

Corporate Vice President, Advanced Technology and Chief Scientific Officer

Edwards Lifesciences

Amy W. Schulman

Managing Partner

LS Polaris Innovation Fund and Polaris Partners

Barry Greene


Alnylam Pharmaceuticals

Robert C. King, PhD

Partner at Goldman Sachs International and Global Vice Chairman

Investment Banking Division

Aharon Aharon


Israel Innovation Authority

Jeroen Tas

Chief Innovation & Strategy Officer


Mark D. Stovsky, MD, MBA, FACS

Senior Director, Emerging Business

Cleveland Clinic Ventures

Tom Sudow

Director, Business Development

Cleveland Clinic Innovations

Corporate Panel

Francois Maisonrouge

Senior Managing Director

Evercore Partners

Zafrira Avnur, PhD

CSO & Partner, VP

Quark Venture Inc.

Laurent Choppe DVM

Managing Partner

Cukierman & Co. Life Sciences

Miriam Frieden, PhD, MBA

VP of Search & Evaluation

Novo Nordisk

Fiona de Hemptinne

Venture Partner

UCB Ventures

Max Zeiberg

Corporate Development

Gilead Sciences

Tina Xu

Vice President of Information Technology and Head of Business Innovation

AstraZeneca China

Cannabis’ Therapeutic Promise: Hope or Hype?

Ayelet Torem, Adv
(Track Co-chair)

Partner, Hi-Tech & Venture Capital and Head of Global Markets

Amit, Pollak, Matalon & Co

Prof. Simon Benita, PhD
(Track Co-chair)

Head of Nano Delivery Systems

Hebrew University of Jerusalem

Dorman Followwill

Senior Partner

Frost & Sullivan

Medy Wiener, MD

Chief Medical Officer

BOL Pharma

Prof. Itamar Raz, MD


The Israeli National Diabetes Council

Prof. Raphael Mechoulam, PhD

Hebrew University of Jerusalem

Prof. Hinanit Koltai, PhD

Agricultural Research Organization (ARO)

Volcani Center

Personalized Medicine and Digital Health: Lessons Learned and Challenges Ahead

Yair Schindel, MD
(Track Co-chair)

Co-Founder & Managing Partner

aMoon Fund

Prof. Varda Shalev, MD, MPA
(Track Co-chair)

Managing Director

Morris Kahn & Maccabi Research and Innovation Institute at Maccabi Health Care Services

Uma Makhija

Business Development Lead, Digital Health

Otsuka Pharmaceuticals

Wade Ackerman

FDA Regulatory group, Co-Lead of Digital Health Initiative

Covington & Burling LLP

Michal Rozen-Zvi

Director, Healthcare Informatics

IBM Research

Prof. Eitan Friedman, MD, PhD

Director & Founder of The Suzanne Levy-Gertner Oncogenetics Unit

Sheba Medical Center

Elliot Menschik, MD, PhD

Global Head, Healthcare + Life Science Startups

Amazon Web Services

Transformative Cancer Therapies

Prof. David Sidransky, MD
(Track Chair)

Johns Hopkins School of Medicine; Co-Founder and General Partner

Israel Biotech Fund

Gary Gordon, MD, PhD

Former Vice President, Global Oncology Development

AbbVie, Inc

Kandeepan Ganeshalingam, MD

Executive Director, Therapeutic Area Head Oncology - EU Clinical Development

Merck Sharp & Dohme

Ulrich Brinkmann, PhD

Scientific Director, Roche Pharma Research & Early Development

Roche Diagnostics GmbH

Gene Editing and Gene Therapy: The Next Frontier in Human Health

Stephen Squinto, PhD
(Track Co-chair)

Interim CEO

Passage Bio

Yael Weiss, MD, PhD
(Track Co-chair)

Vice President Business Development


Adi Barzel, PhD

Senior lecturer, Department of Biochemistry at Tel Aviv University

Co-Founder of LogicBio Therapeutics, Inc.; President of the Israeli Society of Gene and Cell Therapy

Ronald G Crystal, MD

Chair, Department of Genetic Medicine

Weill Cornell Medical College

Trevor Martin, PhD

CEO and Co-Founder

Mammoth Biosciences

Rachel Haurwitz, PhD

Co-founder, President and CEO

Caribou Biosciences

Ulrich Brinkmann, PhD

Scientific Director, Roche Pharma Research & Early Development

Roche Diagnostics GmbH

Prof. Nadav Ahituv, PhD

Department of Bioengineering and Therapeutic Science

University of California San Francisco

Tango of the Two: Academia and Industry

Prof. Yael Hanein, PhD
(Track Co-chair)

School of Electrical Engineering

Tel Aviv University

Shai Policker


Medex Xelerator LP

Regine Shevach

Managing Director

Inter-Lab, an affiliate of Merck KGaA

Tal Dvir

Tel Aviv University

Aviv Zeevi, PhD

VP, Technology Infrastructure

Israel Innovation Authority

Eran Stark, MD, PhD

Sackler Faculty of Medicine

Tel Aviv University

Prof. Gal Markel, MD, PhD

Tel Aviv University

Prof. Daniel Offen, PhD

Tel Aviv University

Prof. David Mirelman, PhD

Weizmann Institute of Science

Prof. Yaakov Nahmais, PhD

Director, Grass Center for Bioengineering

The Hebrew University of Jerusalem

Kelly Krajnik

Senior Manager, Devices, Diagnostics

Mayo Clinic Ventures

Prevention and Rehabilitation: Should the Underdog Begin Barking?

Naomi Gefen
(Track Chair)

Deputy Director General

ALYN Hospital

Itamar Offer, MD, MPA


Sabar Health

Ziv Shilon

Co-founder, COO


Yaron Galitzky

General Manager, Devices & Accessories


Sagit Arbel-Alon, MD

Deputy Director

Reuth Medical & Rehabilitation Hospital

Maurit Beeri, MD

Director General

ALYN Hospital

Disruptive and Advanced Medical Devices

Ron Ginor, MD
(Track Co-chair)

Venture Partner

OrbiMed Advisors

Irit Yaniv, MD
(Track Co-chair)

General Partner


John J. Smith, MD


Hogan Lovells

Bruce R. Rosengard, MD

Vice President, Global External Innovation

Johnson and Johnson Medical Devices

Eric Tansky

Managing Director

Oppenheimer & Co. Inc.

Nicholas Pachuda

WW Vice President, Orthopedic Innovation

J&J Medical Devices

Prof. Joel V. Brill, MD, FACP

Chief Medical Officer

Predictive Health. LLC

Transforming Medicine: Artificial Intelligence and Digital Health

Anat Naschitz
(Track Co-chair)

Managing Director

OrbiMed Advisors

Allen Kamer
(Track Co-chair)

Managing Partner

OurCrowd Qure

Avinatan Hassidim

Head of TLV Research


Don Mathis

General Manager

Growth Comcast NBCUniversal

Leif E. Pedersen


Dassault Systemes BIOVIA

Tamara Mansfeld

Global Innovation Lead


Ziv Ofek

Founder and CEO


Michael Phillips, MD, MBA

Partner and Managing Director

Intermountain Ventures

Hadas Bitran

Head of Healthcare Israel


Elliot Menschik, MD, PhD

Global Head, Healthcare + Life Science Startups

Amazon Web Services

New Modalities of Cell Therapies: Revolutionizing the Way We Treat Diseases

Erez Chimovits
(Track Co-chair)

Senior Managing Director

OrbiMed Advisors

Aya Jakobovits, PhD
(Track Co-chair)

Founder, Director

Adicet Bio

Prof. Ofer Mandelboim, PhD

Hebrew University of Jerusalem

Prof. Angel Progador, PhD

Ben Gurion University

Carl L. Gordon, PhD

Managing Partner

OrbiMed Advisors

Michal J. Besser, PhD

Head of Laboratory, Ella Lemelbaum Institute for Immuno Oncology & Director, Wohl GMP Facility, Sheba Medical Center

Assistant Professor, Dept. of Microbiology and Immunology, School of Medicine, Tel Aviv University